{
  "title": "Affordable, scalable, and accessible | Facts over Fear, Part 2: A high-precision antibody test and promising alternative vaccine for COVID-19",
  "pubDate": "Tue, 28 Apr 2020 15:54:28 +0000",
  "guid": "ee093699-98f7-4941-b44b-dcfcb4b8fa14",
  "link": "https://tonyrobbins.libsyn.com/affordable-scalable-and-accessible-facts-over-fear-part-2-a-high-precision-antibody-test-and-promising-alternative-vaccine-for-covid-19",
  "itunes:image": "",
  "description": "<p><span style=\"font-weight: 400;\">In part 2 of this special edition episode, Tony – along with his friend Dr. Peter Diamandis, the Harvard Medical School trained M.D. and executive founder of Singularity University – explore the present and future of COVID-19. </span></p> <p><span style=\"font-weight: 400;\">If you haven’t heard Part 1, be sure to listen to it, as Dr. Bob Hariri joined the conversation to provide additional context and clarification of the COVID-19 numbers we’re seeing around the clock in the news.</span></p> <p><span style=\"font-weight: 400;\">Today, Tony and Peter speak with Mei Mei Hu and Lou Reese, Co-CEOs of United Biomedical, a company that is now offering an affordable and accurate diagnostic test for COVID-19 through its subsidiary, COVAXX</span></p> <p><span style=\"font-weight: 400;\">Their antibody test is different from others, as it can detect not only if you</span> <em><span style=\"font-weight: 400;\">currently</span></em> <span style=\"font-weight: 400;\">have the virus, but also it signals if you’ve</span> <em><span style=\"font-weight: 400;\">ever had</span></em> <span style=\"font-weight: 400;\">the virus, which is crucial in determining the true rate of mortality associated with COVID-19 – and whether people are immune and therefore able to stop isolating, and go back to work. </span></p> <p><span style=\"font-weight: 400;\">Lou and Mei Mei’s team at COVAXX is also working on a breakthrough alternative option to a traditional vaccine for coronavirus, which you’ll hear discussed in the last half of the episode. </span></p> <p> </p>",
  "content:encoded": "<p>In part 2 of this special edition episode, Tony – along with his friend Dr. Peter Diamandis, the Harvard Medical School trained M.D. and executive founder of Singularity University – explore the present and future of COVID-19. </p> <p>If you haven’t heard Part 1, be sure to listen to it, as Dr. Bob Hariri joined the conversation to provide additional context and clarification of the COVID-19 numbers we’re seeing around the clock in the news.</p> <p>Today, Tony and Peter speak with Mei Mei Hu and Lou Reese, Co-CEOs of United Biomedical, a company that is now offering an affordable and accurate diagnostic test for COVID-19 through its subsidiary, COVAXX</p> <p>Their antibody test is different from others, as it can detect not only if you <em>currently</em> have the virus, but also it signals if you’ve <em>ever had</em> the virus, which is crucial in determining the true rate of mortality associated with COVID-19 – and whether people are immune and therefore able to stop isolating, and go back to work. </p> <p>Lou and Mei Mei’s team at COVAXX is also working on a breakthrough alternative option to a traditional vaccine for coronavirus, which you’ll hear discussed in the last half of the episode. </p> <p> </p>",
  "enclosure": "",
  "itunes:duration": "47:01",
  "itunes:explicit": false,
  "itunes:keywords": "coronavirus,tonyrobbins,peterdiamandis,covid19vaccine,covid19antibodytest,unitedbiomedical,covaxx,meimeihu,loureese",
  "itunes:subtitle": "In part 2 of this special edition episode, Tony – along with his friend Dr. Peter Diamandis, the Harvard Medical School trained M.D. and executive founder of Singularity University – explore the present and future of COVID-19.  If you...",
  "itunes:episodeType": "full"
}